Announcement on Using Partial Idle Raised Funds for Cash Management
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Using Partial Idle Raised Funds for Cash Management
Filed with SSE ·
6ix hasn’t read this filing yet.
Liaoning Chengda Biotechnology Co. Ltd. on 6ix
Earlier from Liaoning Chengda Biotechnology
- Announcement on Voluntary Disclosure of Signing Strategic Cooperation Agreement
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
- Announcement on the 1st Repurchase of Repurchased Shares through Call Auction
- Announcement on Change of Directors of the Company
Later from Liaoning Chengda Biotechnology
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on the Postponement of Certain Fundraising Projects, Adjustment of Internal Investment Structure, and Capital Injection to Wholly-owned Subsidiaries for the Implementation of New Fundraising Subprojects
- Announcement on Adjusting the Internal Investment Structure of Partial Investment Projects Financed by Raised Funds
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Subsidiary Opening a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement on Special Account Deposit of Raised Funds
Follow Liaoning Chengda Biotechnology into a list and get an email when it puts out news.
Follow Liaoning Chengda Biotechnology